Nihon Shokakibyo Gakkai Zasshi
May 2021
Nihon Shokakibyo Gakkai Zasshi
October 2020
Nihon Shokakibyo Gakkai Zasshi
September 2020
Nihon Shokakibyo Gakkai Zasshi
November 2017
In the present study, the usefulness of the resistance-associated variant (RAV) analysis to select direct acting antiviral (DAA) drugs for patients with hepatitis C virus (HCV) genotype/serotype discrepancy was evaluated. The core-genotype and serotype were determined in the 559 patients recruited in the study. The RAV analysis and NS5B-genotype determination were performed in the eight patients who exhibited a genotype/serotype discrepancy.
View Article and Find Full Text PDF